Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot Ulcers

NACompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Diabetic Foot Ulcer
Interventions
OTHER

Standard of Care: Moist Wound Therapy and Offloading

Standard of Care: Moist Wound Therapy and Offloading

OTHER

EpiFix plus Standard of Care

Weekly application of EpiFix and Standard of Care

Trial Locations (20)

23464

Coastal Podiatry, Inc., Virginia Beach

29209

Dorn VA, Columbia

35205

Central Research Associates, Inc., Birmingham

43606

Jobst Vascular Institute, Promedica Toledo Hospital, Toledo

78501

Futuro Clinical Trials, LLC, McAllen

84143

LDS Hospital, Salt Lake City

84157

IMC Wound Care, Murray

90057

Foot & Ankle Clinic, Los Angeles

92201

Novak Urgent Care and Family Practice, Indio

92262

Palmtree Clinical Research, Inc., Palm Springs

92357

Loma Linda VA Medical Center, Loma Linda

93309

Stockdale Podiatry Group, Bakersfield

93720

Valley Vascular Surgery Associates, Fresno

93721

Limb Preservation Platform, Fresno

94115

Center for Clinical Research, San Francisco

94546

Center for Clinical Research Inc, Castro Valley

95628

Center for Clinical Research, Inc., Sacramento

97401

Center for Clinical Research, Inc., Eugene

01702

MetroWest Medical Center, Framingham

02190

South Shore Hospital, Weymouth

All Listed Sponsors
lead

MiMedx Group, Inc.

INDUSTRY

NCT01693133 - Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter